Nikita Shah
Net Worth

Last updated:

What is Nikita Shah net worth?

The estimated net worth of Ms. Nikita Shah is at least $9,771,109 as of 14 Aug 2024. She owns shares worth $2,671,661 as insider, has earned $2,055,808 from insider trading and has received compensation worth at least $5,043,640 in Amneal Pharmaceuticals, Inc..

What is the salary of Nikita Shah?

Ms. Nikita Shah salary is $720,520 per year as Executive Vice President and Chief HR Officer & Strategic Planning Officer in Amneal Pharmaceuticals, Inc..

How old is Nikita Shah?

Ms. Nikita Shah is 47 years old, born in 1978.

What stocks does Nikita Shah currently own?

As insider, Ms. Nikita Shah owns shares in one company:

Company Title Shares Price per share Total value
Amneal Pharmaceuticals, Inc. (AMRX) Executive Vice President and Chief HR Officer & Strategic Planning Officer 291,666 $9.16 $2,671,661

What does Amneal Pharmaceuticals, Inc. do?

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson's disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.

AMRX logo
AMRX
Amneal Pharmaceuticals, Inc.
$9.16

Nikita Shah insider trading

Amneal Pharmaceuticals, Inc.

Ms. Nikita Shah has made 4 insider trades between 2018-2024, according to the Form 4 filled with the SEC. Most recently she sold 100,000 units of AMRX stock worth $775,000 on 14 Aug 2024.

The largest trade she's ever made was exercising 100,000 units of AMRX stock on 14 Aug 2024. As of 14 Aug 2024 she still owns at least 291,666 units of AMRX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Common Stock 100,000 $7.75 $775,000
Option
Class A Common Stock 36,232 N/A N/A
Option
Restricted Stock Units 45,871 N/A N/A
Option
Restricted Stock Units 36,232 N/A N/A
Option
Class A Common Stock 45,871 N/A N/A
Option
Restricted Stock Units 28,957 N/A N/A
Option
Class A Common Stock 28,957 N/A N/A
Option
Restricted Stock Units 35,620 N/A N/A
Option
Class A Common Stock 35,620 N/A N/A
Option
Restricted Stock Units 36,232 N/A N/A
Option
Class A Common Stock 36,232 N/A N/A
Option
Restricted Stock Units 11,729 N/A N/A
Option
Class A Common Stock 28,958 N/A N/A
Option
Restricted Stock Units 28,958 N/A N/A
Option
Class A Common Stock 11,729 N/A N/A
Option
Restricted Stock Units 35,620 N/A N/A
Option
Class A Common Stock 35,620 N/A N/A
Option
Restricted Stock Units 4,442 N/A N/A
Option
Class A Common Stock 4,442 N/A N/A
Option
Restricted Stock Units 11,728 N/A N/A
Option
Restricted Stock Units 28,957 N/A N/A
Option
Class A Common Stock 28,957 N/A N/A
Option
Class A Common Stock 11,728 N/A N/A
Option
Class A Common Stock 35,620 N/A N/A
Option
Restricted Stock Units 35,620 N/A N/A
Sale
Class A Common Stock 2,000 $3.95 $7,900
Option
Restricted Stock Units 4,441 N/A N/A
Option
Class A Common Stock 4,441 N/A N/A
Sale
Class A Common Stock 36,330 $2.75 $99,908
Option
Class A Common Stock 36,330 $2.75 $99,908
Option
Stock Option (Right to Buy) 36,330 $2.75 $99,908
Option
Class A Common Stock 11,729 N/A N/A
Option
Restricted Stock Units 11,729 N/A N/A
Option
Restricted Stock Units 35,620 N/A N/A
Option
Class A Common Stock 35,620 N/A N/A
Option
Restricted Stock Units 4,442 N/A N/A
Option
Class A Common Stock 4,442 N/A N/A
Option
Restricted Stock Units 11,728 N/A N/A
Option
Class A Common Stock 11,728 N/A N/A
Option
Class A Common Stock 4,441 N/A N/A
Option
Restricted Stock Units 4,441 N/A N/A
Sale
Class A Common Stock 50,000 $23.46 $1,173,000

Amneal Pharmaceuticals key executives

Amneal Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Mr. Anastasios G. Konidaris (58) Executive Vice President & Chief Financial Officer
  • Mr. Andrew S. Boyer (59) Executive Vice President & Chief Commercial Officer of Generics
  • Mr. Chintu Patel R.Ph., R.Ph (53) Co-Founder, Co-Chief Executive Officer & Director
  • Mr. Chirag K. Patel (58) Co-Founder, Co-Chief Executive Officer, Pres & Director
  • Mr. Joseph Todisco MBA (49) Executive Vice President & Chief Commercial Officer of Specialty
  • Ms. Nikita Shah (47) Executive Vice President and Chief HR Officer & Strategic Planning Officer